Medication Therapy Management
"Medication Therapy Management" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Assistance in managing and monitoring drug therapy for patients receiving treatment for cancer or chronic conditions such as asthma and diabetes, consulting with patients and their families on the proper use of medication; conducting wellness and disease prevention programs to improve public health; overseeing medication use in a variety of settings.
Descriptor ID |
D054539
|
MeSH Number(s) |
N02.421.668.438 N03.219.521.576.343.575.500.500 N03.219.521.576.343.840.938.500 N04.590.661
|
Concept/Terms |
Medication Therapy Management- Medication Therapy Management
- Management, Medication Therapy
- Therapy Management, Medication
- Drug Therapy Management
- Management, Drug Therapy
- Therapy Management, Drug
|
Below are MeSH descriptors whose meaning is more general than "Medication Therapy Management".
Below are MeSH descriptors whose meaning is more specific than "Medication Therapy Management".
This graph shows the total number of publications written about "Medication Therapy Management" by people in this website by year, and whether "Medication Therapy Management" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2012 | 1 | 2 | 3 |
2013 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
2016 | 0 | 2 | 2 |
2017 | 0 | 1 | 1 |
2018 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Medication Therapy Management" by people in Profiles.
-
Hall M, Dondo TB, Yan AT, Mamas MA, Timmis AD, Deanfield JE, Jernberg T, Hemingway H, Fox KAA, Gale CP. Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort. PLoS Med. 2018 03; 15(3):e1002501.
-
Waldman SA, Terzic A. Process Improvement for Maximized Therapeutic Innovation Outcome. Clin Pharmacol Ther. 2018 Jan; 103(1):8-12.
-
Volpp KG, Troxel AB, Mehta SJ, Norton L, Zhu J, Lim R, Wang W, Marcus N, Terwiesch C, Caldarella K, Levin T, Relish M, Negin N, Smith-McLallen A, Snyder R, Spettell CM, Drachman B, Kolansky D, Asch DA. Effect of Electronic Reminders, Financial Incentives, and Social Support on Outcomes After Myocardial Infarction: The HeartStrong Randomized Clinical Trial. JAMA Intern Med. 2017 08 01; 177(8):1093-1101.
-
Sardar MR, Saeed W, Kowey PR. Antiarrhythmic Drug Therapy for Atrial Fibrillation. Heart Fail Clin. 2016 Apr; 12(2):205-21.
-
Pyrko P, Parvizi J. Renal and Gastrointestinal Considerations in Patients Undergoing Elective Orthopaedic Surgery. Instr Course Lect. 2016; 65:487-95.
-
Sardar MR, Saeed W, Kowey PR. Antiarrhythmic drug therapy for atrial fibrillation. Cardiol Clin. 2014 Nov; 32(4):533-49.
-
Wang J, Keller M. Outdated dermatologic drug samples and obligations to the patient. J Am Acad Dermatol. 2013 Oct; 69(4):643-5.
-
Stefanacci RG, Haimowitz D. Medication management in assisted living. Geriatr Nurs. 2012 Jul-Aug; 33(4):304.e1-12.
-
Berdine H, Dougherty T, Ference J, Karpa K, Klootwyk J, Kozminski M, Leon N, Osborne M, Welch AC, Willey VJ, Peterson A, Stanchak LA, Whisler AG. The pharmacists' role in the Patient-Centered Medical Home (PCMH): a white paper created by the Health Policy Committee of the Pennsylvania Pharmacists Association (PPA). Ann Pharmacother. 2012 May; 46(5):723-50.
-
Stefanacci RG. Financial oversight of medication use: an expanded role for consultant pharmacists. Consult Pharm. 2012 Apr; 27(4):290-5.